Valuation: Imexpharm Corporation

Market Cap 5,637B 217M 193M 180M 164M 309M 20.85B 312M 2.18B 844M 10.66B 814M 797M 34.21B P/E 2026 *
15.9x
P/E 2027 * 14.6x
Enterprise Value 5,637B 217M 193M 180M 164M 309M 20.85B 312M 2.18B 844M 10.66B 814M 797M 34.21B EV / Sales 2026 *
2.12x
EV / Sales 2027 * 1.96x
Free-Float
6.42%
Yield 2026 *
2.73%
Yield 2027 * 2.73%
1 day+0.27%
1 week-0.81%
Current month+1.10%
1 month-8.04%
3 months-12.44%
6 months-34.29%
Current year-30.29%
1 week 34,550
Extreme 34550
36,900
1 month 34,550
Extreme 34550
39,750
Current year 32,650
Extreme 32650
57,000
1 year 32,650
Extreme 32650
57,000
3 years 23,681.82
Extreme 23681.818181
57,000
5 years 18,831.17
Extreme 18831.168829
57,000
10 years 13,036.96
Extreme 13036.963036
57,000
Manager TitleAgeSince
Chief Executive Officer 74 2001-07-31
Director of Finance/CFO 52 2024-01-17
Chief Operating Officer 47 -
Director TitleAgeSince
Chairman 74 1983-12-31
Director/Board Member 50 2018-04-27
Director/Board Member - 2020-05-29
Date Insider Type Main position Quantity % Market Cap. Importance
9/26/22 Buy

Chief Executive Officer

140,000 0.2100%
7/20/22 Sell

Chief Executive Officer

100,000 0.1500%
4/1/22 Exercice

Chairman

50,000 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
+0.27%-0.81%-30.94%+24.33% 216M
-0.61%-3.30%+38.46%+112.77% 1,025B
-1.02%-5.41%+37.61%+64.39% 623B
+1.11%-0.87%+7.55%+76.32% 459B
+0.34%-2.49%+60.10%+40.17% 355B
-0.95%-4.87%+22.46%+38.03% 336B
-1.46%-2.20%+11.84%+23.94% 270B
-1.35%-4.27%-4.55%+6.92% 247B
-1.04%-0.74%+35.02%+49.96% 220B
-1.87%-3.31%+30.22%+93.14% 183B
Average -0.65%-1.76%+20.78%+53.00% 371.84B
Weighted average by Cap. -0.58%-2.11%+29.72%+68.31%

Financials

2026 *2027 *
Net sales 2,659B 102M 90.92M 84.86M 77.34M 146M 9.84B 147M 1.03B 398M 5.03B 384M 376M 16.14B 2,881B 111M 98.51M 91.94M 83.8M 158M 10.66B 160M 1.11B 431M 5.45B 416M 407M 17.49B
Net income 394B 15.16M 13.47M 12.57M 11.46M 21.61M 1.46B 21.82M 152M 58.96M 745M 56.93M 55.69M 2.39B 428B 16.47M 14.63M 13.66M 12.45M 23.48M 1.58B 23.7M 165M 64.05M 809M 61.84M 60.5M 2.6B
Net Debt - -
Logo Imexpharm Corporation
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
Employees
1,438
Date Price Change Volume
26-10-01 ₫36,600.00 +0.27% 1,642
26-10-01 ₫36,500.00 +0.83% 920
26-09-30 ₫36,200.00 -1.63% 3,701
26-09-29 ₫36,800.00 0.00% 929
26-09-28 ₫36,800.00 -0.27% 21,728
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
36,600.00VND
Average target price
56,000.00VND
Spread / Average Target
+53.01%

Annual profits - Rate of surprise